首页 › 基金 › SPHERA FUNDS MANAGEMENT LTD. › ELDN
SPHERA FUNDS MANAGEMENT LTD. 对 ELDN 的持仓历史
ELEDON PHARMACEUTICALS INC · 医疗保健
SPHERA FUNDS MANAGEMENT LTD. 在 Q2 2026 的 13F 申报中披露持有 ELDN(ELEDON PHARMACEUTICALS INC)1,191,187 股,市值约 US$4.7M,约占其申报组合的 0.66%,在其申报持仓中市值排名第 50 位。 SPHERA FUNDS MANAGEMENT LTD. 最近 9 个申报季度中有 9 个季度披露了 ELDN 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
SPHERA FUNDS MANAGEMENT LTD. 对 ELDN 的持仓演变
SPHERA FUNDS MANAGEMENT LTD. 于 Q2 2024 首次披露 ELDN 持仓:1,297,021 股(约 US$3.4M)。 该持仓在 Q4 2024 达到峰值 2,551,619 股,市值约 US$10.5M。 在 9 次申报中,SPHERA FUNDS MANAGEMENT LTD. 3 次增持、4 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 1,191,187 股、市值约 US$4.7M,环比减持 -580,944 股。。 持仓曾出现大幅变动:Q2 2025 减持约 99% (随后一个季度股价下跌 4%)、Q3 2025 增持约 541% (随后一个季度股价下跌 42%)、Q4 2025 增持约 966% (随后一个季度股价上涨 104%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 1.30M | $3.42M | 新进 |
| Q3 2024 | 1.30M | $3.23M | 持有 |
| Q4 2024 | 2.55M | $10.51M | 增持 |
| Q1 2025 | 2.31M | $7.82M | 减持 |
| Q2 2025 | 31.20K | $84.55K | 减持 |
| Q3 2025 | 200.00K | $518.00K | 增持 |
| Q4 2025 | 2.13M | $3.22M | 增持 |
| Q1 2026 | 1.77M | $5.46M | 减持 |
| Q2 2026 | 1.19M | $4.69M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ELDN 与 13F 数据
ELDN(ELEDON PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 40 只申报持有 ELDN,申报仓位最大的包括:BVF INC/IL (US$24.8M), Defilade Capital Management, L.P. (US$13.9M), Catalio Capital Management, LP (US$6.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ELDN 的基金
- BVF INC/IL 6.29M 股 · $24.80M · Q2 2026
- Defilade Capital Management, L.P. 3.53M 股 · $13.89M · Q2 2026
- Catalio Capital Management, LP 1.70M 股 · $6.68M · Q2 2026
- 22NW, LP 636.36K 股 · $2.51M · Q2 2026
- CM Management, LLC 575.00K 股 · $2.27M · Q2 2026
更多关于 SPHERA FUNDS MANAGEMENT LTD.
常见问题
How long has SPHERA FUNDS MANAGEMENT LTD. held ELDN?
SPHERA FUNDS MANAGEMENT LTD. has disclosed ELDN holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is SPHERA FUNDS MANAGEMENT LTD.'s current position in ELDN?
As of Q2 2026, SPHERA FUNDS MANAGEMENT LTD. holds 1.19M shares of ELDN (ELEDON PHARMACEUTICALS INC), valued at $4.69M, representing 0.66% of its reported portfolio and ranking #50.
Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling ELDN?
In the latest 13F filing (Q2 2026), SPHERA FUNDS MANAGEMENT LTD. reduced its position in ELDN. The position peaked in Q4 2024 at 2.55M shares.
Which other funds hold ELDN?
Other major institutional holders of ELDN include BVF INC/IL, Defilade Capital Management, L.P., Catalio Capital Management, LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.